The issue of AMR got personal for her when her mother developed a hospital-acquired urinary tract infection caused by a drug-resistant microbe in 2018 - and continues to battle antimicrobial ...
Spero Therapeutics (SPRO) stock tumbled 20% post-market after the company announced it was cutting its workforce by 39% in the wake of a failed Phase 2 study for its drug SPR720.